Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-24-088813

See remarks sold 42,359 shares at an average $8.34 ($353,071)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rahmer Peter See remarks 2024-07-29 Sale 10b5-1 −1,359 $8.85 $12,027 432,929 D: show line 1 in the form
Rahmer Peter See remarks 2024-07-29 Sale 10b5-1 −12,164 $8.51 $103,516 420,765 D: show line 2 in the form
Rahmer Peter See remarks 2024-07-30 Sale 10b5-1 −15,128 $8.28 $125,260 405,637 D: show line 3 in the form
Rahmer Peter See remarks 2024-07-31 Sale 10b5-1 −13,708 $8.19 $112,269 391,929 D: show line 4 in the form
Open-market sales · 42,359 sh · avg $8.34 · $353,071
Loading xslF345X05/ownership.xml…